Biotech

Update

Biotech

Gene editing, mRNA, and pharma leaders. ISRG RSI 9 EXTREME. CRSP -8.6% continued selloff.

Quick Snapshot

Signal Reading
Overall 🔴 WEAK - Gene editing names selling off, ISRG in freefall
Key insight ISRG RSI 9 = extreme capitulation. CRSP dropped to $45.88 - at $45 support. BEAM RSI 26.
Position update CRSP at $45.88 (-10.6% from entry), momentum portfolio stop-loss hit

Action Matrix

Action Stocks Why
🚨 STOP HIT CRSP Momentum portfolio stop-loss triggered
📈 WATCH ISRG RSI 9 = extreme oversold, surgical robotics leader
📈 WATCH BEAM RSI 26↓ oversold, gene editing
🔍 RESEARCH LLY Dropped to $1020, RSI 48 - approaching entry
🔒 HOLD IONS RSI 69, relative strength

Data (Validated 2026-02-05)

Stock Price 7D 30D 52wkHi RSI Status Action
CRSP $45.88 -14.2% -17.1% -41.5% 36 🟡 At support 🚨 Stop hit
BEAM $24.73 -15.5% -21.3% -32.1% 26↓ 🟢 Oversold 📈 Watch
EDIT $1.66 -14.9% -14.4% -63.4% 35 🔴 Dying ⚠️ Avoid
NTLA $11.09 -13.3% -7.2% -60.7% 46 🟡 Weak 🔍 Watch
ALNY $331.24 -7.3% -13.1% -33.2% 35 🟡 Pullback 🔍 Watch
IONS $83.48 +0.3% +6.3% -3.8% 69 🟢 Strong 🔒 Hold
LLY $1020.84 -3.9% -7.8% -10.0% 48 🟡 Pullback 🔍 Approaching zone
MRNA $40.87 -6.5% +27.0% -26.0% 53 🟡 Fading bounce 🔍 Watch
ISRG $476.32 -12.3% -16.4% -21.8% 9↓ 🟢 EXTREME 📈 Watch

Key Changes vs 2026-02-04

Stock Yesterday Today Move Note
ISRG $490.25 $476.32 -2.8% RSI 9 (was 8) = EXTREME oversold. Surgical robotics monopoly.
CRSP $50.17 $45.88 -8.6% Broke $50 support. Momentum stop-loss hit. At $45 level.
BEAM $27.37 $24.73 -9.6% RSI dropped to 26. Gene editing sector weak.
LLY $1107.12 $1020.84 -7.8% Big drop, now approaching <$1000 entry zone
MRNA $42.77 $40.87 -4.4% Fading from +32.9% 30D recovery
NTLA $12.36 $11.09 -10.3% Small cap gene editing getting crushed
IONS $82.99 $83.48 +0.6% Relative strength, holding up
ALNY $357.57 $331.24 -7.4% Big selloff, RSI 35

Key Positions

CRSP - CRISPR Therapeutics (Stop-Loss Hit)

Thesis: First CRISPR drug (Casgevy) approved. Gene editing pioneer.

Metric Value
Entry $51.31
Current $45.88
Return -10.6%
RSI 36
Support $45

Status: 🚨 Momentum portfolio stop-loss triggered. Long-term thesis position may hold.

Analysis:

  • Broke below $50 support, testing $45
  • Gene editing sector under broad pressure
  • Casgevy commercial ramp is the catalyst to watch
  • If $45 holds, could be a DCA add zone for conviction position

Action: 🚨 Momentum stop-loss hit. Evaluate re-entry at $40-45 with confirmed support.

ISRG - Intuitive Surgical (Extreme Oversold)

Thesis: Surgical robotics monopoly. da Vinci platform.

Metric Value
Current $476.32
30D -16.4%
RSI 9↓ (EXTREME)
52wk High -21.8%

Analysis:

  • RSI 9 = extreme oversold - almost never happens for quality compounder
  • Surgical robotics monopoly with massive installed base
  • Hospital capex cycles don't change overnight
  • This is likely a capitulation bottom signal

Action: 📈 Watch closely for ANY bounce. RSI 9 on a monopoly is generational.

BEAM - Beam Therapeutics (Oversold)

Thesis: Base editing technology. Next-gen gene editing.

Metric Value
Current $24.73
RSI 26↓ (Oversold)
52wk High -32.1%

Analysis:

  • RSI 26 = oversold for a biotech with pipeline
  • Base editing = differentiated from CRISPR
  • High risk/high reward

Action: 📈 Watch for stabilization

Entry Zones Status

Stock Entry Zone Current Status
ISRG <$500 $476.32 ✅ DEEP IN ZONE (RSI 9)
CRSP <$45 $45.88 ⚠️ At zone boundary
LLY <$1000 $1020.84 🔍 Approaching zone

The Gold

Discoveries:

  • ISRG RSI 9 is the most extreme oversold signal in the ENTIRE research system
  • Gene editing sector selling off as a group - may be sector rotation
  • IONS showing relative strength while peers crash

Mistakes:

  • CRSP position entered too early, momentum stop-loss doing its job
  • Should have waited for $45 support before entering

Open Questions:

  • Is ISRG selling off on earnings miss or macro fear? RSI 9 = buy signal?
  • Will CRSP hold $45 or continue to $40?
  • Is LLY approaching a generational entry at <$1000?

Next Actions

  • Evaluate CRSP momentum stop-loss exit
  • Watch ISRG for ANY stabilization at RSI 9
  • Monitor LLY approach to $1000 entry zone
  • Research BEAM pipeline at RSI 26

Commands

cd stonks

the desk's own tooling
the desk's own tooling
the desk's own tooling
the desk's own tooling
10 events
DateTypeEvent
Feb 5 ScanBiotech Scan Mar 10 ScanBiotech Scan Feb 11 ScanBiotech Scan Mar 11 ScanBiotech Scan Feb 26 ScanBiotech Scan Mar 12 ScanBiotech Scan Mar 13 ScanBiotech Scan Feb 16 ScanBiotech Scan Mar 20 ScanBiotech Scan Feb 22 ScanBiotech Scan

No direct external sources are attached to this read.